OBSCN and breast carcinoma: Recently, two variants of long non-coding RNAs were identified on the minus strand of OBSCN, termed OBSCN-Antisense RNA 1/2 (OBSCN-AS1/2), which may have the potential to modify obscurin expression in breast cancer cells, although mutations have not yet been analyzed (Guardia et al., 2021).